» Articles » PMID: 32830857

Bioinformatics Analysis of Prognostic Value of PITX1 Gene in Breast Cancer

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2020 Aug 25
PMID 32830857
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Paired-like homeodomain transcription factor 1 (PITX1) participates in miscellaneous biological processes including cell growth, development, progression and invasion in various malignant tumors. However, the analysis of the association between PITX1 expression and the survival in breast cancer remains unclear.

Methods: Clinical prognostic parameters and survival data related to PITX1 in breast cancer patients were performed using the bioinformatic analysis including Oncomine, Bc-GenExMiner v4.3, PrognoScan and UCSC Xena.

Results: We found that PITX1 gene expression was significantly higher in different histological classification of breast cancer. The Scarff-Bloom-Richardson (SBR) grade, Nottingham prognostic index (NPI), estrogen receptor (ER) negative, epidermal growth factor receptor-2 (HER2) positive, lymph node positive, triple-negative status and basal-like status were positively correlated with PITX1 level, except for patients' age and the progesterone receptor (PR) status. We have found that the increased PITX1 expression correlated with worse relapse-free survival, disease specific survival and overall survival. PITX1 was positively correlated with metastatic relapse-free survival and distant metastasis-free survival. We also confirmed positive correlation between PITX1 and the nucleotide-binding oligomerization domain 2 (NOD2).

Conclusion: The lower expression of PITX1 was associated with better clinical prognostic parameters and clinical survival in breast cancer according to the bioinformatic analysis.

Citing Articles

Identification of transcription factors associated with the disease-free survival of triple-negative breast cancer through weighted gene co-expression network analysis.

Wang H, Hao R, Liu W, Zhang Y, Ma S, Lu Y Cytojournal. 2025; 21:71.

PMID: 39917004 PMC: 11801659. DOI: 10.25259/Cytojournal_127_2024.


Integration of CRISPR/dCas9-Based methylation editing with guide positioning sequencing identifies dynamic changes of mrDEGs in breast cancer progression.

Zhang B, Li J, Yu W Cell Mol Life Sci. 2025; 82(1):46.

PMID: 39833630 PMC: 11747065. DOI: 10.1007/s00018-024-05562-z.


Integration analysis of - and -regulatory long non-coding RNAs associated with immune-related pathways in non-small cell lung cancer.

Liu Y, Yang H, Lv G, Duan J, Zhao W, Shi Y Biochem Biophys Rep. 2024; 40:101832.

PMID: 39539669 PMC: 11558640. DOI: 10.1016/j.bbrep.2024.101832.


EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma.

Li M, Long S, Liu W, Long K, Gao X Front Pharmacol. 2024; 15:1419040.

PMID: 39170698 PMC: 11335561. DOI: 10.3389/fphar.2024.1419040.


Construction of a new prognostic model for colorectal cancer based on bulk RNA-seq combined with The Cancer Genome Atlas data.

Ye Y, Xu G Transl Cancer Res. 2024; 13(6):2704-2720.

PMID: 38988915 PMC: 11231782. DOI: 10.21037/tcr-23-2281.


References
1.
Kong G, Liu Z, Wu K, Zhang Y, Deng Z, Feng W . Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma. Tumour Biol. 2015; 36(10):7735-41. DOI: 10.1007/s13277-015-3512-1. View

2.
Osaki M, Chinen H, Yoshida Y, Ohhira T, Sunamura N, Yamamoto O . Decreased PITX1 gene expression in human cutaneous malignant melanoma and its clinicopathological significance. Eur J Dermatol. 2013; 23(3):344-9. DOI: 10.1684/ejd.2013.2021. View

3.
Yamamizu K, Sharov A, Piao Y, Amano M, Yu H, Nishiyama A . Generation and gene expression profiling of 48 transcription-factor-inducible mouse embryonic stem cell lines. Sci Rep. 2016; 6:25667. PMC: 4858678. DOI: 10.1038/srep25667. View

4.
Downward J . RNA interference libraries prove their worth in hunt for tumor suppressor genes. Cell. 2005; 121(6):813-5. DOI: 10.1016/j.cell.2005.06.002. View

5.
Otsubo T, Yamada K, Hagiwara T, Oshima K, Iida K, Nishikata K . DNA hypermethyation and silencing of correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma. Oncotarget. 2017; 8(48):84434-84448. PMC: 5663609. DOI: 10.18632/oncotarget.21375. View